← Back to Search

Double Voiding for Urinary Tract Infection Prevention Post-Kidney Transplant

Led By Muthukumar Thangamani, M.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up first 3 months of transplantation
Awards & highlights

Study Summary

This trial will assess if "double voiding" reduces UTI risk for kidney transplant recipients, lowering the risk of infection and rejection of the organ.

Who is the study for?
This trial is for adult kidney transplant recipients who are being routinely followed at the NYP-WCM Transplant Clinic. It's not for those discharged with an indwelling catheter (Foley) after their transplant.Check my eligibility
What is being tested?
The study compares 'double voiding'—a technique to empty the bladder more completely—with regular voiding to see if it reduces urinary tract infections in new kidney transplant patients.See study design
What are the potential side effects?
There are no direct side effects from participating in this trial as it involves non-invasive techniques of urination, but UTIs themselves can cause discomfort, fever, and may require antibiotics.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 3 months of transplantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and first 3 months of transplantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of UTI's
Secondary outcome measures
Bacterial colony count of each positive urine culture
Number of UTI episodes
Number of hospital admissions
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Double VoidingExperimental Treatment1 Intervention
The participant will be instructed to void twice.
Group II: Regular VoidingActive Control1 Intervention
The participant will be instructed to void normally.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,090 Total Patients Enrolled
Muthukumar Thangamani, M.D.Principal InvestigatorWeill Medical College of Cornell University

Media Library

Double Voiding Clinical Trial Eligibility Overview. Trial Name: NCT05711446 — N/A
Urinary Tract Infection Research Study Groups: Double Voiding, Regular Voiding
Urinary Tract Infection Clinical Trial 2023: Double Voiding Highlights & Side Effects. Trial Name: NCT05711446 — N/A
Double Voiding 2023 Treatment Timeline for Medical Study. Trial Name: NCT05711446 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment phase for this experiment ongoing?

"Clinicaltrials.gov data indicates that this trial is not presently enrolling participants, despite its initial posting on February 1st 2023 and last update two days later. Fortunately, there are 800 other trials currently searching for volunteers to take part in the study."

Answered by AI
~268 spots leftby Dec 2025